Documents
Data to early diagnosis and precision medicine challenge evaluation: progress and process evaluation report (PDF)
If you cannot open or read this document, you can ask for a different format.
Request a different format
Email web@ukri.org, telling us:
- the name of the document
- what format you need
- any assistive technology you use (such as type of screen reader).
Find out about our approach to the accessibility of our website.
Details
This document discusses the comprehensive assessment of the D2EDPM challenge funded by UKRI.
Initiated in 2020, this intricate programme aims to quicken the utilisation of data and emerging technologies in disease diagnosis and precision medicine adoption.
The SQW-led consortium carries out the evaluation in four stages:
- evaluation framework development
- baseline assessment
- interim progress and process evaluation
- the forthcoming impact evaluation
At this point, the report presents key findings from the third stage based on monitoring returns from project managers and consultations with 69 stakeholders.
The D2EDPM challenge has multiple objectives, ranging from encouraging the adoption of precision medicines to fostering the growth of UK-based companies in this sector.
Despite pandemic-related delays and various project complexities, progress is being made towards these objectives with particular achievements in the genomics and digital innovation hubs strands.
The evaluation anticipates that the challenge will meet its target budget and outputs by the final phase in 2023.
Moreover, the summary discusses improvements that can be made in the remainder of the challenge, including:
- enhanced external and internal communication
- promoting collaboration
- establishing a long-term plan to build on the challenge’s achievements